Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis

Molecular and Cellular Endocrinology

Volumn 397, Issue 1-2, 2014, Pages 78-92

  Méndez Giménez, Leire ^a,b   Rodríguez, Amaia ^a,b   Balaguer, Inmaculada ^a   Frühbeck, Gema ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Aquaporin; Caveolin; Glycerol; Insulin signaling; Lipid metabolism; Obesity

Indexed keywords

AQUAGLYCEROPORIN; CAVEOLIN; INSULIN;

ENERGY METABOLISM; FATTY LIVER; GENETICS; GLUCONEOGENESIS; HOMEOSTASIS; HUMAN; LIPOGENESIS; LIVER; METABOLIC DISORDER; METABOLISM; OBESITY; PHYSIOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

AQUAGLYCEROPORINS; CAVEOLINS; ENERGY METABOLISM; FATTY LIVER; GLUCONEOGENESIS; HOMEOSTASIS; HUMANS; INSULIN; LIPOGENESIS; LIVER; METABOLIC DISEASES; OBESITY; SIGNAL TRANSDUCTION;

EID: 84914178934     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.06.017     Document Type: Review

References (219)

1. Agre P., Kozono D. Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett 2003, 555:72-78.
2. Agre P., Preston G.M., Smith B.L., Jung J.S., Raina S., Moon C., Guggino W.B., Nielsen S. Aquaporin CHIP: the archetypal molecular water channel. Am. J. Physiol 1993, 265:F463-476.
3. Alias L., Gallano P., Moreno D., Pujol R., Martinez-Matos J.A., Baiget M., Ferrer I., Olive M. A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia. Neuromuscul. Disord 2004, 14:321-324.
4. Ardissone A., Bragato C., Caffi L., Blasevich F., Maestrini S., Bianchi M.L., Morandi L., Moroni I., Mora M. Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy. BMC Med. Genet 2013, 14:89.
5. Asterholm I.W., Mundy D.I., Weng J., Anderson R.G., Scherer P.E. Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab 2012, 15:171-185.
6. Azad A.K., Yoshikawa N., Ishikawa T., Sawa Y., Shibata H. Substitution of a single amino acid residue in the aromatic/arginine selectivity filter alters the transport profiles of tonoplast aquaporin homologs. Biochim. Biophys. Acta 2012, 1818:1-11.
7. Bahamontes-Rosa N., Tena-Tomas C., Wolkow J., Kremsner P.G., Kun J.F. Genetic conservation of the GIL blood group determining aquaporin 3 gene in African and Caucasian populations. Transfusion 2008, 48:1164-1168.
8. Balbis A., Baquiran G., Mounier C., Posner B.I. Effect of insulin on caveolin-enriched membrane domains in rat liver. J. Biol. Chem 2004, 279:39348-39357.
9. Bastiani M., Liu L., Hill M.M., Jedrychowski M.P., Nixon S.J., Lo H.P., Abankwa D., Luetterforst R., Fernandez-Rojo M., Breen M.R., Gygi S.P., Vinten J., Walser P.J., North K.N., Hancock J.F., Pilch P.F., Parton R.G. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. J. Cell Biol 2009, 185:1259-1273.
10. Beitz E., Wu B., Holm L.M., Schultz J.E., Zeuthen T. Point mutations in the aromatic/arginine region in aquaporin 1 allow passage of urea, glycerol, ammonia, and protons. Proc. Natl. Acad. Sci. USA 2006, 103:269-274.
11. Best L., Brown P.D., Yates A.P., Perret J., Virreira M., Beauwens R., Malaisse W.J., Sener A., Delporte C. Contrasting effects of glycerol and urea transport on rat pancreatic beta-cell function. Cell. Physiol. Biochem 2009, 23:255-264.
12. Betz R.C., Schoser B.G., Kasper D., Ricker K., Ramirez A., Stein V., Torbergsen T., Lee Y.A., Nothen M.M., Wienker T.F., Malin J.P., Propping P., Reis A., Mortier W., Jentsch T.J., Vorgerd M., Kubisch C. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat. Genet 2001, 28:218-219.
13. Bienert G.P., Moller A.L., Kristiansen K.A., Schulz A., Moller I.M., Schjoerring J.K., Jahn T.P. Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J. Biol. Chem 2007, 282:1183-1192.
14. Bosch M., Marí M., Herms A., Fernández A., Fajardo A., Kassan A., Giralt A., Colell A., Balgoma D., Barbero E., González-Moreno E., Matias N., Tebar F., Balsinde J., Camps M., Enrich C., Gross S.P., García-Ruiz C., Pérez-Navarro E., Fernández-Checa J.C., Pol A. Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. Curr. Biol 2011, 21:681-686.
15. Briand N., Le Lay S., Sessa W.C., Ferre P., Dugail I. Distinct roles of endothelial and adipocyte caveolin-1 in macrophage infiltration and adipose tissue metabolic activity. Diabetes 2011, 60:448-453.
16. Butler T.L., Au C.G., Yang B., Egan J.R., Tan Y.M., Hardeman E.C., North K.N., Verkman A.S., Winlaw D.S. Cardiac aquaporin expression in humans, rats, and mice. Am. J. Physiol. Heart Circ. Physiol 2006, 291:H705-713.
17. Cagliani R., Bresolin N., Prelle A., Gallanti A., Fortunato F., Sironi M., Ciscato P., Fagiolari G., Bonato S., Galbiati S., Corti S., Lamperti C., Moggio M., Comi G.P. A CAV3 microdeletion differentially affects skeletal muscle and myocardium. Neurology 2003, 61:1513-1519.
18. Calamita G., Ferri D., Gena P., Carreras F.I., Liquori G.E., Portincasa P., Marinelli R.A., Svelto M. Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis. Am. J. Physiol. Gastrointest. Liver Physiol 2008, 295:G682-690.
19. Campo A., Frühbeck G., Zulueta J.J., Iriarte J., Seijo L.M., Alcaide A.B., Galdiz J.B., Salvador J. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur. Respir. J. 2007, 30:223-231.
20. Candreia C., Schmuziger N., Gurtler N. Molecular analysis of aquaporin genes 1 to 4 in patients with Meniere's disease. Cell. Physiol. Biochem 2010, 26:787-792.
21. Cao H. Adipocytokines in obesity and metabolic disease. J. Endocrinol 2014, 220:T47-59.
22. Cao H., Alston L., Ruschman J., Hegele R.A. Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia. Lipids Health Dis 2008, 7:3.
23. Capozza F., Combs T.P., Cohen A.W., Cho Y.R., Park S.Y., Schubert W., Williams T.M., Brasaemle D.L., Jelicks L.A., Scherer P.E., Kim J.K., Lisanti M.P. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am. J. Physiol. Cell Physiol 2005, 288:C1317-1331.
24. Carbone I., Bruno C., Sotgia F., Bado M., Broda P., Masetti E., Panella A., Zara F., Bricarelli FD., Cordone G., Lisanti MP., Minetti C. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000, 54:1373-1376.
25. Carver L.A., Schnitzer J.E. Caveolae: mining little caves for new cancer targets. Nat. Rev. Cancer 2003, 3:571-581.
26. Catalán V., Gómez-Ambrosi J., Rotellar F., Silva C., Gil M.J., Rodríguez A., Cienfuegos J.A., Salvador J., Frühbeck G. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus. Clin. Endocrinol. (Oxf) 2007, 66:598-601.
27. Catalán V., Gómez-Ambrosi J., Rodríguez A., Silva C., Rotellar F., Gil M.J., Cienfuegos J.A., Salvador J., Frühbeck G. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation. Clin. Endocrinol 2008, 68:213-219.
28. Catalán V., Gómez-Ambrosi J., Pastor C., Rotellar F., Silva C., Rodríguez A., Gil M.J., Cienfuegos J.A., Salvador J., Vendrell J., Frühbeck G. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver. Obes. Surg 2008, 18:695-701.
29. Catteruccia M., Sanna T., Santorelli F.M., Tessa A., Di Giacopo R., Sauchelli D., Verbo A., Lo Monaco M., Servidei S. Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene. Neuromuscul. Disord 2009, 19:779-783.
30. Cawthorn W.P., Scheller E.L., MacDougald O.A. Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J. Lipid Res 2012, 53:227-246.
31. Ceperuelo-Mallafré V., Miranda M., Chacón M.R., Vilarrasa N., Megia A., Gutiérrez C., Fernández-Real J.M., Gómez J.M., Caubet E., Frühbeck G., Vendrell J. Adipose tissue expression of the glycerol channel aquaporin-7 gene is altered in severe obesity but not in type 2 diabetes. J. Clin. Endocrinol. Metab 2007, 92:3640-3645.
32. Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., Charlton, M., Sanyal, A.J., 2012. American Gastroenterological A, American Association for the Study of Liver D, American College of G The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142:1592-1609.
33. Chanprasertyothin S., Saetung S., Rajatanavin R., Ongphiphadhanakul B. Genetic variant in the aquaporin 9 gene is associated with bone mineral density in postmenopausal women. Endocrine 2010, 38:83-86.
34. Choudhury A., Marks D.L., Proctor K.M., Gould G.W., Pagano R.E. Regulation of caveolar endocytosis by syntaxin 6-dependent delivery of membrane components to the cell surface. Nat. Cell Biol 2006, 8:317-328.
35. Cohen A.W., Razani B., Wang X.B., Combs T.P., Williams T.M., Scherer P.E., Lisanti M.P. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am. J. Physiol. Cell Physiol 2003, 285:C222-235.
36. Cohen A.W., Razani B., Schubert W., Williams T.M., Wang X.B., Iyengar P., Brasaemle D.L., Scherer P.E., Lisanti M.P. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 2004, 53:1261-1270.
37. Delporte C., Virreira M., Crutzen R., Louchami K., Sener A., Malaisse W.J., Beauwens R. Functional role of aquaglyceroporin 7 expression in the pancreatic beta-cell line BRIN-BD11. J. Cell. Physiol 2009, 221:424-429.
38. Dietzen D.J., Hastings W.R., Lublin D.M. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J. Biol. Chem 1995, 270:6838-6842.
39. Ding S.Y., Lee M.J., Summer R., Liu L., Fried S.K., Pilch P.F. Pleiotropic effects of Cavin-1 deficiency on lipid metabolism. J. Biol. Chem 2014, 289:8473-8483.
40. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293:2449-2452.
41. Echevarría M., Windhager E.E., Tate S.S., Frindt G. Cloning and expression of AQP3, a water channel from the medullary collecting duct of rat kidney. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:10997-11001.
42. Engelman J.A., Zhang X., Galbiati F., Volonte D., Sotgia F., Pestell R.G., Minetti C., Scherer P.E., Okamoto T., Lisanti M.P. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, alzheimer disease, and muscular dystrophy. Am. J. Hum. Genet 1998, 63:1578-1587.
43. Fagerholm S., Ortegren U., Karlsson M., Ruishalme I., Stralfors P. Rapid insulin-dependent endocytosis of the insulin receptor by caveolae in primary adipocytes. PLoS ONE 2009, 4:e5985.
44. Falcão-Pires I., Castro-Chaves P., Miranda-Silva D., Lourenco A.P., Leite-Moreira A.F. Physiological, pathological and potential therapeutic roles of adipokines. Drug. Discov. Today 2012, 17:880-889.
45. Fasshauer M., Klein J., Lossner U., Klier M., Kralisch S., Paschke R. Suppression of aquaporin adipose gene expression by isoproterenol, TNFalpha, and dexamethasone. Horm. Metab. Res 2003, 35:222-227.
46. Fernández M.A., Albor C., Ingelmo-Torres M., Nixon S.J., Ferguson C., Kurzchalia T., Tebar F., Enrich C., Parton R.G., Pol A. Caveolin-1 is essential for liver regeneration. Science 2006, 313:1628-1632.
47. Fernandez-Hernando C., Yu J., Davalos A., Prendergast J., Sessa W.C. Endothelial-specific overexpression of caveolin-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol 2010, 177:998-1003.
48. Fernandez-Rojo M.A., Restall C., Ferguson C., Martel N., Martin S., Bosch M., Kassan A., Leong G.M., Martin S.D., McGee S.L., Muscat G.E., Anderson R.L., Enrich C., Pol A., Parton R.G. Caveolin-1 orchestrates the balance between glucose and lipid-dependent energy metabolism: implications for liver regeneration. Hepatology 2012, 55:1574-1584.
49. Feron O., Belhassen L., Kobzik L., Smith T.W., Kelly R.A., Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem 1996, 271:22810-22814.
50. Fisher E., Schreiber S., Joost H.G., Boeing H., Doring F. A two-step association study identifies CAV2 rs2270188 single nucleotide polymorphism interaction with fat intake in type 2 diabetes risk. J. Nutr 2011, 141:177-181.
51. Frank P.G., Lisanti M.P. Caveolin-1 and liver regeneration: role in proliferation and lipogenesis. Cell Cycle 2007, 6:115-116.
52. Frank P.G., Marcel Y.L., Connelly M.A., Lublin D.M., Franklin V., Williams D.L., Lisanti M.P. Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I. Biochemistry 2002, 41:11931-11940.
53. Frank P.G., Lee H., Park D.S., Tandon N.N., Scherer P.E., Lisanti M.P. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol 2004, 24:98-105.
54. Frühbeck G. Obesity: aquaporin enters the picture. Nature 2005, 438:436-437.
55. Frühbeck G., Gómez-Ambrosi J. Rationale for the existence of additional adipostatic hormones. FASEB J 2001, 15:1996-2006.
56. Frühbeck G., Gómez-Ambrosi J., Salvador J. Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB J. 2001, 15:333-340.
57. Frühbeck G., Catalán V., Gómez-Ambrosi J., Rodríguez A. Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways. Trends Pharmacol. Sci 2006, 27:345-347.
58. Frühbeck G., López M., Diéguez C. Role of caveolins in body weight and insulin resistance regulation. Trends Endocrinol. Metab 2007, 18:177-182.
59. Frühbeck, G., Toplak, H., Woodward, E., Yumuk, V., Maislos, M., Oppert, J.M., 2013. Executive Committee of the European Association for the Study of Obesity Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts 6: 117-120.
60. Frühbeck G., Méndez-Giménez L., Fernández-Formoso J.A., Fernández S., Rodríguez A. Regulation of adipocyte lipolysis. Nutr. Res. Rev 2014, 27:63-93.
61. Fu Y., Moore X.L., Lee M.K., Fernandez-Rojo M.A., Parat M.O., Parton R.G., Meikle P.J., Sviridov D., Chin-Dusting J.P. Caveolin-1 plays a critical role in the differentiation of monocytes into macrophages. Arterioscler. Thromb. Vasc. Biol 2012, 32:e117-125.
62. Fulizio L., Nascimbeni A.C., Fanin M., Piluso G., Politano L., Nigro V., Angelini C. Molecular and muscle pathology in a series of caveolinopathy patients. Hum. Mutat 2005, 25:82-89.
63. Galbiati F., Engelman J.A., Volonte D., Zhang X.L., Minetti C., Li M., Hou H., Kneitz B., Edelmann W., Lisanti M.P. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J. Biol. Chem 2001, 276:21425-21433.
64. Garg A. Clinical review#: lipodystrophies: genetic and acquired body fat disorders. J. Clin. Endocrinol. Metab 2011, 96:3313-3325.
65. Garg A., Agarwal A.K. Caveolin-1: a new locus for human lipodystrophy. J. Clin. Endocrinol. Metab 2008, 93:1183-1185.
66. Gladka M., El Azzouzi H., De Windt L.J., da Costa Martins P.A. Aquaporin 7: the glycerol aquaeductus in the heart. Cardiovasc. Res 2009, 83:3-4.
67. Gonzales A.M., Orlando R.A. Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutr. Metab (Lond) 2007, 4:22.
68. González-Muñoz E., López-Iglesias C., Calvo M., Palacín M., Zorzano A., Camps M. Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes. Endocrinology 2009, 150:3493-3502.
69. Goossens G.H. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol. Behav 2008, 94:206-218.
70. Goubau C., Jaeken J., Levtchenko E.N., Thys C., Di Michele M., Martens G.A., Gerlo E., De Vos R., Buyse G.M., Goemans N., Van Geet C., Freson K. Homozygosity for aquaporin 7 G264V in three unrelated children with hyperglyceroluria and a mild platelet secretion defect. Genet. Med 2013, 15:55-63.
71. Grilo A., Fernandez M.L., Beltran M., Ramirez-Lorca R., Gonzalez M.A., Royo J.L., Gutierrez-Tous R., Moron F.J., Couto C., Serrano-Rios M., Saez M.E., Ruiz A., Real L.M. Genetic analysis of CAV1 gene in hypertension and metabolic syndrome. Thromb. Haemost 2006, 95:696-701.
72. Guan H.P., Li Y., Jensen M.V., Newgard C.B., Steppan C.M., Lazar M.A. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat. Med 2002, 8:1122-1128.
73. Gustincich S., Vatta P., Goruppi S., Wolf M., Saccone S., Della Valle G., Baggiolini M., Schneider C. The human serum deprivation response gene (SDPR) maps to 2q32-q33 and codes for a phosphatidylserine-binding protein. Genomics 1999, 57:120-129.
74. Hansen C.G., Nichols B.J. Exploring the caves: cavins, caveolins and caveolae. Trends Cell Biol 2010, 20:177-186.
75. Hansen C.G., Bright N.A., Howard G., Nichols B.J. SDPR induces membrane curvature and functions in the formation of caveolae. Nat. Cell Biol 2009, 11:807-814.
76. Hansen C.G., Shvets E., Howard G., Riento K., Nichols B.J. Deletion of cavin genes reveals tissue-specific mechanisms for morphogenesis of endothelial caveolae. Nat. Commun 2013, 4:1831.
77. Hara M., Ma T., Verkman A.S. Selectively reduced glycerol in skin of aquaporin-3-deficient mice may account for impaired skin hydration, elasticity, and barrier recovery. J. Biol. Chem 2002, 277:46616-46621.
78. Hara-Chikuma M., Verkman A.S. Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J. Mol. Med 2008, 86:221-231.
79. Hara-Chikuma M., Verkman A.S. Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption. Mol. Cell. Biol 2008, 28:326-332.
80. Hara-Chikuma M., Sohara E., Rai T., Ikawa M., Okabe M., Sasaki S., Uchida S., Verkman A.S. Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation. J. Biol. Chem 2005, 280:15493-15496.
81. Harris C.A., Haas J.T., Streeper R.S., Stone S.J., Kumari M., Yang K., Han X., Brownell N., Gross R.W., Zechner R., Farese R.V. DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes. J. Lipid Res 2011, 52:657-667.
82. Hassan G.S., Jasmin J.F., Schubert W., Frank P.G., Lisanti M.P. Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 2004, 43:8312-8321.
83. Hatakeyama S., Yoshida Y., Tani T., Koyama Y., Nihei K., Ohshiro K., Kamiie J.I., Yaoita E., Suda T., Hatakeyama K., Yamamoto T. Cloning of a new aquaporin (AQP10) abundantly expressed in duodenum and jejunum. Biochem. Biophys. Res. Commun 2001, 287:814-819.
84. Hayashi T., Arimura T., Ueda K., Shibata H., Hohda S., Takahashi M., Hori H., Koga Y., Oka N., Imaizumi T., Yasunami M., Kimura A. Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun 2004, 313:178-184.
85. Hayashi Y.K., Matsuda C., Ogawa M., Goto K., Tominaga K., Mitsuhashi S., Park Y.E., Nonaka I., Hino-Fukuyo N., Haginoya K., Sugano H., Nishino I. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J. Clin. Invest 2009, 119:2623-2633.
86. Hegele R.A., Joy T.R., Al-Attar S.A., Rutt B.K. Thematic review series: adipocyte biology. Lipodystrophies: windows on adipose biology and metabolism. J. Lipid Res 2007, 48:1433-1444.
87. Herrmann R., Straub V., Blank M., Kutzick C., Franke N., Jacob E.N., Lenard H.G., Kroger S., Voit T. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum. Mol. Genet 2000, 9:2335-2340.
88. Hibuse T., Maeda N., Funahashi T., Yamamoto K., Nagasawa A., Mizunoya W., Kishida K., Inoue K., Kuriyama H., Nakamura T., Fushiki T., Kihara S., Shimomura I. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc. Natl. Acad. Sci. USA 2005, 102:10993-10998.
89. Hibuse T., Maeda N., Nakatsuji H., Tochino Y., Fujita K., Kihara S., Funahashi T., Shimomura I. The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator. Cardiovasc. Res 2009, 83:34-41.
90. Hill M.M., Bastiani M., Luetterforst R., Kirkham M., Kirkham A., Nixon S.J., Walser P., Abankwa D., Oorschot V.M., Martin S., Hancock J.F., Parton R.G. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 2008, 132:113-124.
91. Inoue M., Wakayama Y., Kojima H., Shibuya S., Jimi T., Hara H., Iijima S., Masaki H., Oniki H., Matsuzaki Y. Aquaporin 9 expression and its localization in normal skeletal myofiber. J. Mol. Histol 2009, 40:165-170.
92. Inouye M., Ripatti S., Kettunen J., Lyytikainen L.P., Oksala N., Laurila P.P., Kangas A.J., Soininen P., Savolainen M.J., Viikari J., Kahonen M., Perola M., Salomaa V., Raitakari O., Lehtimaki T., Taskinen M.R., Jarvelin M.R., Ala-Korpela M., Palotie A., de Bakker P.I. Novel loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet 2012, 8:e1002907.
93. Ishibashi K., Kuwahara M., Gu Y., Kageyama Y., Tohsaka A., Suzuki F., Marumo F., Sasaki S. Cloning and functional expression of a new water channel abundantly expressed in the testis permeable to water, glycerol, and urea. J. Biol. Chem 1997, 272:20782-20786.
94. Ishibashi K., Yamauchi K., Kageyama Y., Saito-Ohara F., Ikeuchi T., Marumo F., Sasaki S. Molecular characterization of human Aquaporin-7 gene and its chromosomal mapping. Biochim. Biophys. Acta 1998, 1399:62-66.
95. Ishibashi K., Kuwahara M., Gu Y., Tanaka Y., Marumo F., Sasaki S. Cloning and functional expression of a new aquaporin (AQP9) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol. Biochem. Biophys. Res. Commun 1998, 244:268-274.
96. Ishibashi K., Tanaka Y., Morishita Y. The role of mammalian superaquaporins inside the cell. Biochim. Biophys. Acta 2014, 1840:1507-1512.
97. Jansa P., Mason S.W., Hoffmann-Rohrer U., Grummt I. Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes. EMBO J. 1998, 17:2855-2864.
98. Jelen S., Wacker S., Aponte-Santamaria C., Skott M., Rojek A., Johanson U., Kjellbom P., Nielsen S., de Groot B.L., Rutzler M. Aquaporin-9 protein is the primary route of hepatocyte glycerol uptake for glycerol gluconeogenesis in mice. J. Biol. Chem 2011, 286:44319-44325.
99. Jung J.S., Preston G.M., Smith B.L., Guggino W.B., Agre P. Molecular structure of the water channel through aquaporin CHIP. The hourglass model. J. Biol. Chem 1994, 269:14648-14654.
100. Kim C.A., Delepine M., Boutet E., El Mourabit H., Le Lay S., Meier M., Nemani M., Bridel E., Leite C.C., Bertola D.R., Semple R.K., O'Rahilly S., Dugail I., Capeau J., Lathrop M., Magre J. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J. Clin. Endocrinol. Metab 2008, 93:1129-1134.
101. King L.S., Kozono D., Agre P. From structure to disease: the evolving tale of aquaporin biology. Nat. Rev. Mol. Cell Biol 2004, 5:687-698.
102. Kishida K., Kuriyama H., Funahashi T., Shimomura I., Kihara S., Ouchi N., Nishida M., Nishizawa H., Matsuda M., Takahashi M., Hotta K., Nakamura T., Yamashita S., Tochino Y., Matsuzawa Y. Aquaporin adipose, a putative glycerol channel in adipocytes. J. Biol. Chem 2000, 275:20896-20902.
103. Kishida K., Shimomura I., Nishizawa H., Maeda N., Kuriyama H., Kondo H., Matsuda M., Nagaretani H., Ouchi N., Hotta K., Kihara S., Kadowaki T., Funahashi T., Matsuzawa Y. Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor gamma. J. Biol. Chem 2001, 276:48572-48579.
104. Kishida K., Shimomura I., Kondo H., Kuriyama H., Makino Y., Nishizawa H., Maeda N., Matsuda M., Ouchi N., Kihara S., Kurachi Y., Funahashi T., Matsuzawa Y. Genomic structure and insulin-mediated repression of the aquaporin adipose (AQPap), adipose-specific glycerol channel. J. Biol. Chem 2001, 276:36251-36260.
105. Kolditz C.I., Langin D. Adipose tissue lipolysis. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:377-381.
106. Kondo H., Shimomura I., Kishida K., Kuriyama H., Makino Y., Nishizawa H., Matsuda M., Maeda N., Nagaretani H., Kihara S., Kurachi Y., Nakamura T., Funahashi T., Matsuzawa Y. Human aquaporin adipose (AQPap) gene. Genomic structure, promoter analysis and functional mutation. Eur. J. Biochem 2002, 269:1814-1826.
107. Krahmer N., Farese R.V., Walther T.C. Balancing the fat: lipid droplets and human disease. EMBO Mol. Med 2013, 5:905-915.
108. Kuriyama H., Kawamoto S., Ishida N., Ohno I., Mita S., Matsuzawa Y., Matsubara K., Okubo K. Molecular cloning and expression of a novel human aquaporin from adipose tissue with glycerol permeability. Biochem. Biophys. Res. Commun 1997, 241:53-58.
109. Kuriyama H., Shimomura I., Kishida K., Kondo H., Furuyama N., Nishizawa H., Maeda N., Matsuda M., Nagaretani H., Kihara S., Nakamura T., Tochino Y., Funahashi T., Matsuzawa Y. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. Diabetes 2002, 51:2915-2921.
110. Lafontan M., Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog. Lipid Res 2009, 48:275-297.
111. Laforenza U., Scaffino M.F., Gastaldi G. Aquaporin-10 represents an alternative pathway for glycerol efflux from human adipocytes. PLoS ONE 2013, 8:e54474.
112. Le Lay S., Hajduch E., Lindsay M.R., Le Liepvre X., Thiele C., Ferre P., Parton R.G., Kurzchalia T., Simons K., Dugail I. Cholesterol-induced caveolin targeting to lipid droplets in adipocytes: a role for caveolar endocytosis. Traffic 2006, 7:549-561.
113. Le Lay S., Briand N., Blouin C.M., Chateau D., Prado C., Lasnier F., Le Liepvre X., Hajduch E., Dugail I. The lipoatrophic caveolin-1 deficient mouse model reveals autophagy in mature adipocytes. Autophagy 2010, 6:754-763.
114. Lebeck J. Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver. J. Mol. Endocrinol 2014, 52:R165-R178.
115. Lesseur C., Gilbert-Diamond D., Andrew A.S., Ekstrom R.M., Li Z., Kelsey K.T., Marsit C.J., Karagas M.R. A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire. Toxicol. Lett 2012, 210:100-106.
116. Li S., Seitz R., Lisanti M.P. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J. Biol. Chem 1996, 271:3863-3868.
117. Li J., Scherl A., Medina F., Frank P.G., Kitsis R.N., Tanowitz H.B., Sotgia F., Lisanti M.P. Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle 2005, 4:1599-1607.
118. Li H., Kamiie J., Morishita Y., Yoshida Y., Yaoita E., Ishibashi K., Yamamoto T. Expression and localization of two isoforms of AQP10 in human small intestine. Biol. Cell 2005, 97:823-829.
119. Liu Z., Shen J., Carbrey J.M., Mukhopadhyay R., Agre P., Rosen B.P. Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:6053-6058.
120. Liu L., Brown D., McKee M., Lebrasseur N.K., Yang D., Albrecht K.H., Ravid K., Pilch P.F. Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab 2008, 8:310-317.
121. Louchami K., Best L., Brown P., Virreira M., Hupkens E., Perret J., Devuyst O., Uchida S., Delporte C., Malaisse W.J., Beauwens R., Sener A. A new role for aquaporin 7 in insulin secretion. Cell. Physiol. Biochem 2012, 29:65-74.
122. Ma T., Frigeri A., Hasegawa H., Verkman A.S. Cloning of a water channel homolog expressed in brain meningeal cells and kidney collecting duct that functions as a stilbene-sensitive glycerol transporter. J. Biol. Chem 1994, 269:21845-21849.
123. Ma T., Song Y., Yang B., Gillespie A., Carlson E.J., Epstein C.J., Verkman A.S. Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels. Proc. Natl. Acad. Sci. USA 2000, 97:4386-4391.
124. Ma T., Hara M., Sougrat R., Verbavatz J.M., Verkman A.S. Impaired stratum corneum hydration in mice lacking epidermal water channel aquaporin-3. J. Biol. Chem 2002, 277:17147-17153.
125. Madeira A., Camps M., Zorzano A., Moura T.F., Soveral G. Biophysical assessment of human aquaporin-7 as a water and glycerol channel in 3T3-L1 adipocytes. PLoS ONE 2013, 8:e83442.
126. Madeira, A., Fernandez-Veledo, S., Camps, M., Zorzano, A., Moura, T.F., Ceperuelo-Mallafré, V., Vendrell, J., Soveral, G., 2014. Human aquaporin-11 is a water and glycerol channel and localizes in the vicinity of lipid droplets in human adipocytes. Obesity: doi: . doi:10.1002/oby.20792.
127. Maeda N. Implications of aquaglyceroporins 7 and 9 in glycerol metabolism and metabolic syndrome. Mol. Aspects Med 2012, 33:665-675.
128. Maeda N., Funahashi T., Hibuse T., Nagasawa A., Kishida K., Kuriyama H., Nakamura T., Kihara S., Shimomura I., Matsuzawa Y. Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. Proc. Natl. Acad. Sci. USA 2004, 101:17801-17806.
129. Marrades M.P., Milagro F.I., Martínez J.A., Moreno-Aliaga M.J. Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Biochem. Biophys. Res. Commun 2006, 339:785-789.
130. Martin S., Parton R.G. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell Biol 2006, 7:373-378.
131. Martin S., Fernandez-Rojo M.A., Stanley A.C., Bastiani M., Okano S., Nixon S.J., Thomas G., Stow J.L., Parton R.G. Caveolin-1 deficiency leads to increased susceptibility to cell death and fibrosis in white adipose tissue: characterization of a lipodystrophic model. PLoS ONE 2012, 7:e46242.
132. Mastrodonato M., Calamita G., Rossi R., Mentino D., Bonfrate L., Portincasa P., Ferri D., Liquori G.E. Altered distribution of caveolin-1 in early liver steatosis. Eur. J. Clin. Invest 2011, 41:642-651.
133. Matsumura K., Chang B.H., Fujimiya M., Chen W., Kulkarni R.N., Eguchi Y., Kimura H., Kojima H., Chan L. Aquaporin 7 is a beta-cell protein and regulator of intraislet glycerol content and glycerol kinase activity, beta-cell mass, and insulin production and secretion. Mol. Cell. Biol 2007, 27:6026-6037.
134. McMahon K.A., Zajicek H., Li W.P., Peyton M.J., Minna J.D., Hernandez V.J., Luby-Phelps K., Anderson R.G. SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J. 2009, 28:1001-1015.
135. McNally E.M., de Sa Moreira E., Duggan D.J., Bonnemann C.G., Lisanti M.P., Lidov H.G., Vainzof M., Passos-Bueno M.R., Hoffman E.P., Zatz M., Kunkel L.M. Caveolin-3 in muscular dystrophy. Hum. Mol. Genet 1998, 7:871-877.
136. Merlini L., Carbone I., Capanni C., Sabatelli P., Tortorelli S., Sotgia F., Lisanti M.P., Bruno C., Minetti C. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J. Neurol. Neurosurg. Psychiatry 2002, 73:65-67.
137. Millán J., Hewlett L., Glyn M., Toomre D., Clark P., Ridley A.J. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat. Cell Biol 2006, 8:113-123.
138. Mineo C., Ying Y.S., Chapline C., Jaken S., Anderson R.G. Targeting of protein kinase Calpha to caveolae. J. Cell Biol 1998, 141:601-610.
139. Minetti C., Sotgia F., Bruno C., Scartezzini P., Broda P., Bado M., Masetti E., Mazzocco M., Egeo A., Donati M.A., Volonte D., Galbiati F., Cordone G., Bricarelli F.D., Lisanti M.P., Zara F. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat. Genet 1998, 18:365-368.
140. Miranda M., Ceperuelo-Mallafré V., Lecube A., Hernández C., Chacón M.R., Fort J.M., Gallart L., Baena-Fustegueras J.A., Simo R., Vendrell J. Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity: relationship with glucose abnormalities. Metabolism 2009, 58:1762-1768.
141. Mobasheri A., Shakibaei M., Marples D. Immunohistochemical localization of aquaporin 10 in the apical membranes of the human ileum: a potential pathway for luminal water and small solute absorption. Histochem. Cell Biol 2004, 121:463-471.
142. Monier S., Parton R.G., Vogel F., Behlke J., Henske A., Kurzchalia T.V. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell 1995, 6:911-927.
143. Montell E., Lerin C., Newgard C.B., Gomez-Foix A.M. Effects of modulation of glycerol kinase expression on lipid and carbohydrate metabolism in human muscle cells. J. Biol. Chem 2002, 277:2682-2686.
144. Morinaga T., Nakakoshi M., Hirao A., Imai M., Ishibashi K. Mouse aquaporin 10 gene (AQP10) is a pseudogene. Biochem. Biophys. Res. Commun 2002, 294:630-634.
145. Murakami N., Hayashi Y.K., Oto Y., Shiraishi M., Itabashi H., Kudo K., Nishino I., Nonaka I., Nagai T. Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood. Neuromuscul. Disord 2013, 23:441-444.
146. Murata M., Peranen J., Schreiner R., Wieland F., Kurzchalia T.V., Simons K. VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. USA 1995, 92:10339-10343.
147. Murphy D.J. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res 2001, 40:325-438.
148. Ogata T., Naito D., Nakanishi N., Hayashi Y.K., Taniguchi T., Miyagawa K., Hamaoka T., Maruyama N., Matoba S., Ikeda K., Yamada H., Oh H., Ueyama T. MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by alpha1-adrenergic receptors. Proc. Natl. Acad. Sci. USA 2014, 111:3811-3816.
149. Oliva R., Calamita G., Thornton J.M., Pellegrini-Calace M. Electrostatics of aquaporin and aquaglyceroporin channels correlates with their transport selectivity. Proc. Natl. Acad. Sci. USA 2010, 107:4135-4140.
150. Oshikawa J., Otsu K., Toya Y., Tsunematsu T., Hankins R., Kawabe J., Minamisawa S., Umemura S., Hagiwara Y., Ishikawa Y. Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc. Natl. Acad. Sci. USA 2004, 101:12670-12675.
151. Ost A., Ortegren U., Gustavsson J., Nystrom F.H., Stralfors P. Triacylglycerol is synthesized in a specific subclass of caveolae in primary adipocytes. J. Biol. Chem 2005, 280:5-8.
152. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol 2011, 11:85-97.
153. Palade G.E. Fine structure of blood capillaries. J. Appl. Phys 1953, 24:1424.
154. Parton R.G., del Pozo M.A. Caveolae as plasma membrane sensors, protectors and organizers. Nat. Rev. Mol. Cell Biol 2013, 14:98-112.
155. Parton R.G., Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol 2007, 8:185-194.
156. Pavlides S., Gutierrez-Pajares J.L., Danilo C., Lisanti M.P., Frank P.G. Atherosclerosis, caveolae and caveolin-1. Adv. Exp. Med. Biol 2012, 729:127-144.
157. Pavlides S., Gutierrez-Pajares J.L., Iturrieta J., Lisanti M.P., Frank P.G. Endothelial caveolin-1 plays a major role in the development of atherosclerosis. Cell Tissue Res 2014, 356:147-157.
158. Pelkmans L., Zerial M. Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae. Nature 2005, 436:128-133.
159. Peroni O., Large V., Beylot M. Measuring gluconeogenesis with [2-13C]glycerol and mass isotopomer distribution analysis of glucose. Am. J. Physiol 1995, 269:E516-523.
160. Pohl J., Ring A., Stremmel W. Uptake of long-chain fatty acids in HepG2 cells involves caveolae: analysis of a novel pathway. J. Lipid Res 2002, 43:1390-1399.
161. Pol A., Martin S., Fernandez M.A., Ingelmo-Torres M., Ferguson C., Enrich C., Parton R.G. Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies. Mol. Biol. Cell 2005, 16:2091-2105.
162. Potter J.J., Koteish A., Hamilton J., Liu X., Liu K., Agre P., Mezey E. Effects of acetaldehyde on hepatocyte glycerol uptake and cell size: implication of aquaporin 9. Alcohol. Clin. Exp. Res 2011, 35:939-945.
163. Poulain-Godefroy O., Lecoeur C., Pattou F., Frühbeck G., Froguel P. Inflammation is associated with a decrease of lipogenic factors in omental fat in women. Am. J. Physiol. Regul. Integr. Comp. Physiol 2008, 295:R1-7.
164. Prudente S., Flex E., Morini E., Turchi F., Capponi D., De Cosmo S., Tassi V., Guida V., Avogaro A., Folli F., Maiani F., Frittitta L., Dallapiccola B., Trischitta V. A functional variant of the adipocyte glycerol channel aquaporin 7 gene is associated with obesity and related metabolic abnormalities. Diabetes 2007, 56:1468-1474.
165. Qiu Y., Liu S., Chen H.T., Yu C.H., Teng X.D., Yao H.T., Xu G.Q. Upregulation of caveolin-1 and SR-B1 in mice with non-alcoholic fatty liver disease. Hepatobiliary Pancreatol. Dis. Int 2013, 12:630-636.
166. Rajab A., Straub V., McCann L.J., Seelow D., Varon R., Barresi R., Schulze A., Lucke B., Lutzkendorf S., Karbasiyan M., Bachmann S., Spuler S., Schuelke M. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet 2010, 6:e1000874.
167. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., Macaluso F., Russell R.G., Li M., Pestell R.G., Di Vizio D., Hou H., Kneitz B., Lagaud G., Christ G.J., Edelmann W., Lisanti M.P. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem 2001, 276:38121-38138.
168. Razani B., Woodman S.E., Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol. Rev 2002, 54:431-467.
169. Razani B., Combs T.P., Wang X.B., Frank P.G., Park D.S., Russell R.G., Li M., Tang B., Jelicks L.A., Scherer P.E., Lisanti M.P. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J. Biol. Chem 2002, 277:8635-8647.
170. Reijneveld J.C., Ginjaar I.B., Frankhuizen W.S., Notermans N.C. CAV3 gene mutation analysis in patients with idiopathic hyper-CK-emia. Muscle Nerve 2006, 34:656-658.
171. Reshef L., Olswang Y., Cassuto H., Blum B., Croniger C.M., Kalhan S.C., Tilghman S.M., Hanson R.W. Glyceroneogenesis and the triglyceride/fatty acid cycle. J. Biol. Chem 2003, 278:30413-30416.
172. Ring A., Le Lay S., Pohl J., Verkade P., Stremmel W. Caveolin-1 is required for fatty acid translocase (FAT/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts. Biochim. Biophys. Acta 2006, 1761:416-423.
173. Rodríguez A., Catalán V., Gómez-Ambrosi J., Frühbeck G. Role of aquaporin-7 in the pathophysiological control of fat accumulation in mice. FEBS Lett 2006, 580:4771-4776.
174. Rodríguez A., Catalán V., Becerril S., Sáinz N., Salvador J., Gómez-Ambrosi J., Frühbeck G. Aquaporins and their metabolic implications. Obes. Metab 2007, 3:58-67.
175. Rodríguez A., Catalán V., Gómez-Ambrosi J., Frühbeck G. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?. Curr. Pharm. Des 2007, 13:2169-2175.
176. Rodríguez A., Gómez-Ambrosi J., Catalán V., Gil M.J., Becerril S., Sáinz N., Silva C., Salvador J., Colina I., Frühbeck G. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int. J. Obes 2009, 33:541-552.
177. Rodríguez A., Catalán V., Gómez-Ambrosi J., García-Navarro S., Rotellar F., Valentí V., Silva C., Gil M.J., Salvador J., Burrell M.A., Calamita G., Malagón M.M., Frühbeck G. Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. J. Clin. Endocrinol. Metab 2011, 96:E586-597.
178. Rodríguez A., Catalán V., Gómez-Ambrosi J., Frühbeck G. Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control. Cell Cycle 2011, 10:1548-1556.
179. Rodríguez A., Gena P., Méndez-Giménez L., Rosito A., Valentí V., Rotellar F., Sola I., Moncada R., Silva C., Svelto M., Salvador J., Calamita G., Frühbeck G. Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease. Int. J. Obes 2013, 10.1038/ijo.2013.234.
180. Rojek A.M., Skowronski M.T., Fuchtbauer E.M., Fuchtbauer A.C., Fenton R.A., Agre P., Frokiaer J., Nielsen S. Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. Proc. Natl. Acad. Sci. USA 2007, 104:3609-3614.
181. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell 1992, 68:673-682.
182. Roudier N., Ripoche P., Gane P., Le Pennec P.Y., Daniels G., Cartron J.P., Bailly P. AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL. J. Biol. Chem 2002, 277:45854-45859.
183. Sáinz N., Rodríguez A., Catalán V., Becerril S., Ramírez B., Gómez-Ambrosi J., Frühbeck G. Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS ONE 2009, 4:e6808.
184. Scherer P.E., Lisanti M.P., Baldini G., Sargiacomo M., Mastick C.C., Lodish H.F. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell Biol 1994, 127:1233-1243.
185. Scherer P.E., Okamoto T., Chun M., Nishimoto I., Lodish H.F., Lisanti M.P. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA 1996, 93:131-135.
186. Scully T. Public health: society at large. Nature 2014, 508:S50-51.
187. Shastry S., Delgado M.R., Dirik E., Turkmen M., Agarwal A.K., Garg A. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Am. J. Med. Genet. A 2010, 152A:2245-2253.
188. Shen F.X., Gu X., Pan W., Li W.P., Li W., Ye J., Yang L.J., Gu X.J., Ni L.S. Over-expression of AQP7 contributes to improve insulin resistance in adipocytes. Exp. Cell Res 2012, 318:2377-2384.
189. Shin J.S., Gao Z., Abraham S.N. Involvement of cellular caveolae in bacterial entry into mast cells. Science 2000, 289:785-788.
190. Singh P., Peterson T.E., Sert-Kuniyoshi F.H., Glenn J.A., Davison D.E., Romero-Corral A., Pusalavidyasagar S., Jensen M.D., Somers V.K. Leptin signaling in adipose tissue: role in lipid accumulation and weight gain. Circ. Res 2012, 111:599-603.
191. Skelly R.H., Wicksteed B., Antinozzi P.A., Rhodes C.J. Glycerol-stimulated proinsulin biosynthesis in isolated pancreatic rat islets via adenoviral-induced expression of glycerol kinase is mediated via mitochondrial metabolism. Diabetes 2001, 50:1791-1798.
192. Skowronski M.T., Lebeck J., Rojek A., Praetorius J., Fuchtbauer E.M., Frokiaer J., Nielsen S. AQP7 is localized in capillaries of adipose tissue, cardiac and striated muscle: implications in glycerol metabolism. Am. J. Physiol. Renal. Physiol 2007, 292:F956-965.
193. Song K.S., Scherer P.E., Tang Z., Okamoto T., Li S., Chafel M., Chu C., Kohtz D.S., Lisanti M.P. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem 1996, 271:15160-15165.
194. Soria L.R., Fanelli E., Altamura N., Svelto M., Marinelli R.A., Calamita G. Aquaporin-8-facilitated mitochondrial ammonia transport. Biochem. Biophys. Res. Commun 2010, 393:217-221.
195. Strålfors P. Caveolins and caveolae, roles in insulin signalling and diabetes. Adv. Exp. Med. Biol 2012, 729:111-126.
196. Sundblom J., Stalberg E., Osterdahl M., Rucker F., Montelius M., Kalimo H., Nennesmo I., Islander G., Smits A., Dahl N., Melberg A. Bedside diagnosis of rippling muscle disease in CAV3 p. A46T mutation carriers. Muscle Nerve 2010, 41:751-757.
197. Traverso M., Bruno C., Broccolini A., Sotgia F., Donati M.A., Assereto S., Gazzerro E., Lo Monaco M., Modoni A., D'Amico A., Gasperini S., Ricci E., Zara F., Lisanti M., Minetti C. Truncation of caveolin-3 causes autosomal-recessive rippling muscle disease. J. Neurol. Neurosurg. Psychiatry 2008, 79:735-737.
198. Trigatti B.L., Anderson R.G., Gerber G.E. Identification of caveolin-1 as a fatty acid binding protein. Biochem. Biophys. Res. Commun 1999, 255:34-39.
199. Tsai T.H., Chen S.F., Huang T.Y., Tzeng C.F., Chiang A.S., Kou Y.R., Lee T.S., Shyue S.K. Impaired Cd14 and Cd36 expression, bacterial clearance, and toll-like receptor 4-Myd88 signaling in caveolin-1-deleted macrophages and mice. Shock 2011, 35:92-99.
200. Ueyama H., Horinouchi H., Obayashi K., Hashinaga M., Okazaki T., Kumamoto T. Novel homozygous mutation of the caveolin-3 gene in rippling muscle disease with extraocular muscle paresis. Neuromuscul. Disord 2007, 17:558-561.
201. Ullrich N.D., Fischer D., Kornblum C., Walter M.C., Niggli E., Zorzato F., Treves S. Alterations of excitation-contraction coupling and excitation coupled Ca(2+) entry in human myotubes carrying CAV3 mutations linked to rippling muscle. Hum. Mutat 2011, 32:309-317.
202. Umenishi F., Verkman A.S., Gropper M.A. Quantitative analysis of aquaporin mRNA expression in rat tissues by RNase protection assay. DNA Cell Biol 1996, 15:475-480.
203. Utzschneider K.M., Kahn S.E. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab 2006, 91:4753-4761.
204. Verbavatz J.M., Brown D., Sabolic I., Valenti G., Ausiello D.A., Van Hoek A.N., Ma T., Verkman A.S. Tetrameric assembly of CHIP28 water channels in liposomes and cell membranes: a freeze-fracture study. J. Cell Biol 1993, 123:605-618.
205. Verkman A.S., Anderson M.O., Papadopoulos M.C. Aquaporins: important but elusive drug targets. Nat. Rev. Drug. Discover 2014, 13:259-277.
206. Vigouroux C., Caron-Debarle M., Le Dour C., Magré J., Capeau J. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Int. J. Biochem. Cell Biol 2011, 43:862-876.
207. Wakayama Y., Jimi T., Inoue M., Kojima H., Shibuya S., Murahashi M., Hara H., Oniki H. Expression of aquaporin 3 and its localization in normal skeletal myofibres. Histochem. J. 2002, 34:331-337.
208. Wakayama Y., Inoue M., Kojima H., Jimi T., Shibuya S., Hara H., Oniki H. Expression and localization of aquaporin 7 in normal skeletal myofiber. Cell Tissue Res 2004, 316:123-129.
209. Wakayama Y., Hirako S., Ogawa T., Jimi T., Shioda S. Upregulated expression of AQP 7 in the skeletal muscles of obese ob/ob mice. Acta Histochem. Cytochem 2014, 47:27-33.
210. Walker C.G., Holness M.J., Gibbons G.F., Sugden M.C. Fasting-induced increases in aquaporin 7 and adipose triglyceride lipase mRNA expression in adipose tissue are attenuated by peroxisome proliferator-activated receptor alpha deficiency. Int. J. Obes 2007, 31:1165-1171.
211. Way M., Parton R.G. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 1995, 376:108-112.
212. Wendel A.A., Cooper D.E., Ilkayeva O.R., Muoio D.M., Coleman R.A. Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation. J. Biol. Chem 2013, 288:27299-27306.
213. Wu C.C., Wang S.H., Kuan I.I., Tseng W.K., Chen M.F., Wu J.C., Chen Y.L. OxLDL upregulates caveolin-1 expression in macrophages: role for caveolin-1 in the adhesion of oxLDL-treated macrophages to endothelium. J. Cell. Biochem 2009, 107:460-472.
214. Yamada E. The fine structures of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol 1955, 1:445-458.
215. Yamamoto M., Toya Y., Schwencke C., Lisanti M.P., Myers M.G., Ishikawa Y. Caveolin is an activator of insulin receptor signaling. J. Biol. Chem 1998, 273:26962-26968.
216. Yamazaki H., Oda M., Takahashi Y., Iguchi H., Yoshimura K., Okada N., Yokomori H. Relation between ultrastructural localization, changes in caveolin-1, and capillarization of liver sinusoidal endothelial cells in human hepatitis C-related cirrhotic liver. J. Histochem. Cytochem 2013, 61:169-176.
217. Yasui M., Hazama A., Kwon T.H., Nielsen S., Guggino W.B., Agre P. Rapid gating and anion permeability of an intracellular aquaporin. Nature 1999, 402:184-187.
218. Yasui H., Kubota M., Iguchi K., Usui S., Kiho T., Hirano K. Membrane trafficking of aquaporin 3 induced by epinephrine. Biochem. Biophys. Res. Commun 2008, 373:613-617.
219. Yumuk V., Frühbeck G., Oppert J.M., Woodward E., Toplak H. An EASO position statement on multidisciplinary obesity management in adults. Obes Facts 2014, 7:96-101.